| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/18/2013 | US8465989 Method and system for detecting a target within a population of molecules |
| 06/18/2013 | US8465988 Cell-based antioxidant protection assay |
| 06/18/2013 | US8465981 Polypeptides, systems, and methods useful for detecting glucose |
| 06/18/2013 | US8465980 Urine and serum biomarkers associated with diabetic nephropathy |
| 06/18/2013 | US8465979 Method for detecting tin |
| 06/18/2013 | US8465978 Method for conducting platelete aggregation analysis by a cartridge device |
| 06/18/2013 | US8465977 Method and apparatus for lighted test strip |
| 06/18/2013 | US8465966 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA |
| 06/18/2013 | US8465944 Horizontal antigen retrieval |
| 06/18/2013 | US8465943 Methods for identifying stem cells based on nuclear morphotypes |
| 06/18/2013 | US8465939 Aging-related circulating particle-associated lipoprotein B oxidase (apoBNOX) and inhibitors thereof |
| 06/18/2013 | US8465938 Method for producing complex of biotin-labeled Cypridina (Cypridina noctiluca) luciferase with streptoavidin and method for stabilizing the same |
| 06/18/2013 | US8465937 Methods for identifying B-clones which bind cell-surface antigens |
| 06/18/2013 | US8465936 Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy |
| 06/18/2013 | US8465935 Detection and quantitation of cyclodextrins |
| 06/18/2013 | US8465934 Use of protein SATB2 as a marker for colorectal cancer |
| 06/18/2013 | US8465933 Method for screening human ABO blood group-binding lactobacilli |
| 06/18/2013 | US8465932 Method for the determination of trichinella infections and diagnostic composition for such methods |
| 06/18/2013 | US8465931 Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor |
| 06/18/2013 | US8465930 Method for detection of disease having insulin-resistant conditions |
| 06/18/2013 | US8465929 Biomarkers for ovarian cancer |
| 06/18/2013 | US8465916 Variations in kinase domain gene confers sensitivity to tyrosine kinase inhibitor gefitnib |
| 06/18/2013 | US8465743 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 06/18/2013 | US8465734 Methods for increasing protein polyethylene glycol (PEG) conjugation |
| 06/18/2013 | US8465727 Biomarkers for the diagnosis of ALS |
| 06/18/2013 | US8465706 On-demand microfluidic droplet or bubble generation |
| 06/18/2013 | US8465700 High-throughput solvent evaporator and gas manifold with uniform flow rates and independent flow controls |
| 06/18/2013 | US8465698 Microfluidic apparatus with integrated porous-substrate/sensor for real-time (BIO) chemical molecule detection |
| 06/18/2013 | US8465697 System and method for regulating flow in fluidic devices |
| 06/18/2013 | US8465695 Washing test apparatus |
| 06/18/2013 | US8465694 Oligonucleotide synthesizer |
| 06/18/2013 | US8465669 Monolith separation medium for chromatography and process for producing the same |
| 06/18/2013 | US8464572 In-situ sensor for automated measurements of gas content in liquid and related system and method |
| 06/18/2013 | CA2799163A1 Methods and algorithms for aiding in the detection of cancer |
| 06/18/2013 | CA2763114C Multi-well plate and electrode assemblies for ion channel assay methods |
| 06/18/2013 | CA2728022C Hand-held analysis device for analyzing a body fluid and a control method therefor |
| 06/18/2013 | CA2633754C Microrna-based methods and compositions for the diagnosis and treatment of solid cancers |
| 06/18/2013 | CA2600092C Method for determining absolute density of cement slurry |
| 06/18/2013 | CA2519626C Thyroid hormone analysis by mass spectrometry with minimal sample preparation |
| 06/18/2013 | CA2481512C Peptide inhibitors of protein kinase c.gamma. for pain management |
| 06/18/2013 | CA2459348C Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/18/2013 | CA2452849C Method for monitoring and modulating protein folding |
| 06/18/2013 | CA2440028C Rearranged squamous cell carcinoma antigen genes ii |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/18/2013 | CA2278523C Rna binding protein and binding site useful for expression of recombinant molecules |
| 06/17/2013 | CA2841173A1 Uses of labeled hsp90 inhibitors |
| 06/15/2013 | CA2771621A1 Methods for diagnosing alzheimer's disease |
| 06/13/2013 | WO2013086533A1 Neutralizing antibodies to hiv-1 and their use |
| 06/13/2013 | WO2013086524A1 Compositions and methods for characterizing thyroid neoplasia |
| 06/13/2013 | WO2013086509A1 Flow chamber assembly and methods of using the same |
| 06/13/2013 | WO2013086506A1 Idh1-mutated human glioblastoma cell lines and xenografts |
| 06/13/2013 | WO2013086478A1 Materials and methods for diagnosis of malignant melanoma and prognosis of metastasis of malignant melanoma |
| 06/13/2013 | WO2013086450A1 Diagnosis of lymphoid malignancies and minimal residual disease detection |
| 06/13/2013 | WO2013086428A1 Apparatus, system and method for identifying circulating tumor cells |
| 06/13/2013 | WO2013086424A1 Mdm2-containing double minute chromosomes and methods therefore |
| 06/13/2013 | WO2013086365A2 Biomarkers for kidney cancer and methods using the same |
| 06/13/2013 | WO2013086359A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 06/13/2013 | WO2013086352A1 Prostate cancer associated circulating nucleic acid biomarkers |
| 06/13/2013 | WO2013086308A1 Compositions and methods for treating brain cancer |
| 06/13/2013 | WO2013086306A1 Biomarkers for brain injury |
| 06/13/2013 | WO2013086304A1 Methods and compositions for diagnosing neurodegenerative disease |
| 06/13/2013 | WO2013086293A1 In vivo label-free histology by photoacoustic microscopy of cell nuclei |
| 06/13/2013 | WO2013086284A1 Flow chambers, methods of using the flow chamber, and methods of making the flow chamber |
| 06/13/2013 | WO2013086230A1 In vitro medical diagnostic device, cartridge, and systems and methods |
| 06/13/2013 | WO2013086142A1 Method to determine the dra in a hydrocarbon fuel |
| 06/13/2013 | WO2013086074A1 Clot protection and detection algorithm for activated clotting time testing |
| 06/13/2013 | WO2013086070A1 Methods for determining total body skeletal muscle mass |
| 06/13/2013 | WO2013086041A1 Transcriptome wiring analysis in parkinson's disease and uses thereof |
| 06/13/2013 | WO2013086031A1 Method of therapy selection for patients with cancer |
| 06/13/2013 | WO2013086019A1 Use of humanized mice to determine toxicity |
| 06/13/2013 | WO2013085909A1 Human conducting airway model comprising multiple fluidic pathways |
| 06/13/2013 | WO2013085893A1 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 06/13/2013 | WO2013085851A2 Recombinant deamidated gliadin antigen |
| 06/13/2013 | WO2013085818A1 Methods for detecting reverse triiodothyronine by mass spectrometry |
| 06/13/2013 | WO2013085797A1 Method of washing cells using passive separation of a lysed blood sample with clean buffer using inertial microfluidic separation and focusing in spiral microchannels |
| 06/13/2013 | WO2013085715A1 Graphene-biomolecule bioelectronic devices |
| 06/13/2013 | WO2013085604A1 Reduction of galectin-3 levels by plasmapheresis |
| 06/13/2013 | WO2013085482A1 Compositions and methods for monitoring and detecting cancerous conditions |
| 06/13/2013 | WO2013085464A1 Method for preparing improved cardiomyocyte-like cells |
| 06/13/2013 | WO2013085462A1 Arrangement for detection of hemolysis |
| 06/13/2013 | WO2013085367A1 Cardiac troponin i-targeting peptide and use thereof |
| 06/13/2013 | WO2013085359A1 Continuous biological water treatment system using an automatic water quality measuring device for optimizing residence time |
| 06/13/2013 | WO2013085358A1 Continuous biological water treatment system using an active sludge model simulation for optimizing residence time |
| 06/13/2013 | WO2013085348A1 Novel method for measuring platelet activity, and apparatus using same |
| 06/13/2013 | WO2013085344A1 Method for screening material for prevention or treatment of osteoporosis using leptin secretion of mesenchymal stem cells |
| 06/13/2013 | WO2013084950A1 Method for detecting protein-protein interaction |
| 06/13/2013 | WO2013084917A1 Pyrophosphoric acid detection method using immobilized boronic acid support body |
| 06/13/2013 | WO2013084678A1 Optical system and method for determining presence or absence of viral particles using same |
| 06/13/2013 | WO2013084578A1 Evaluation method, screening method, antipruritic substance, and antipruritic agent |
| 06/13/2013 | WO2013084504A1 Method for predicting hypertension |
| 06/13/2013 | WO2013084074A2 Spectroscopic troponin i detection and quantification using plasmonic nano-materials |
| 06/13/2013 | WO2013084002A2 Method for detecting nucleosome adducts |
| 06/13/2013 | WO2013083973A1 Method and system for gas detection |
| 06/13/2013 | WO2013083906A1 Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv) |
| 06/13/2013 | WO2013083866A1 Use of anti-beta-lactoglobulin antibodies in the diagnosis and monitoring of celiac disease |
| 06/13/2013 | WO2013083851A1 Screening assays for compounds for use in the treatment of stress-related disorders |
| 06/13/2013 | WO2013083822A1 Sequential aliqoting and determination of an indicator of sedimentation rate |
| 06/13/2013 | WO2013083754A1 Method for detection of bacteria in milk |
| 06/13/2013 | WO2013083720A1 Antibodies anti-spla2-x and uses thereof |
| 06/13/2013 | WO2013083716A1 Method and system for monitoring a gearbox of a wind energy installation and corresponding wind energy installation |